Bristol-Myers Squibb Company Free Cash Flow 2007–2025
Bristol-Myers Squibb Company reported $12.85B of free cash flow for fiscal 2025. That was 7.9% lower than fiscal 2024. Compared with fiscal 2020, the change was -3.4%.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $12.85B | -7.9% |
| FY 2024 | $13.94B | +10.2% |
| FY 2023 | $12.65B | +5.9% |
| FY 2022 | $11.95B | -21.6% |
| FY 2021 | $15.23B | +14.5% |
| FY 2020 | $13.30B | +80.3% |
| FY 2019 | $7.37B | +20.6% |
| FY 2018 | $6.12B | +44.9% |
| FY 2017 | $4.22B | +129.0% |
| FY 2016 | $1.84B | +43.4% |
| FY 2015 | $1.28B | -51.0% |
| FY 2014 | $2.62B | -12.8% |
| FY 2013 | $3.01B | -52.9% |
| FY 2012 | $6.39B | +42.9% |
| FY 2011 | $4.47B | +10.0% |
| FY 2010 | $4.07B | +21.9% |
| FY 2009 | $3.33B | +20.6% |
| FY 2008 | $2.77B | +19.7% |
| FY 2007 | $2.31B | — |
Source: Bristol-Myers Squibb Company SEC filings — cash flow statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Bristol-Myers Squibb Company reported $12.85B of free cash flow for fiscal 2025. That was 7.9% lower than fiscal 2024. Compared with fiscal 2020, the change was -3.4%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Bristol-Myers Squibb Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBristol-Myers Squibb Company — frequently asked questions
What is Bristol-Myers Squibb Company's free cash flow?
Bristol-Myers Squibb Company (BMY) reported free cash flow of $12.85B for fiscal year 2025, per its SEC filings.
How has Bristol-Myers Squibb Company's free cash flow changed over time?
Between fiscal 2007 and 2025, BMY's free cash flow grew at roughly 10.0% per year (compound annual rate), from $2.31B to $12.85B.
Where does this data come from?
Figures are computed from Bristol-Myers Squibb Company's official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.